Conference on Retroviruses and Opportunistic Infections (CROI 2023), Seattle, Washington, 19-22 February 2023

• Oral Presentation:
• Page-B score to estimate the hepatocellular carcinoma risk in people with HIV and HBV by Bernard Surial on behalf of the Swiss HIV Cohort Study, ATHENA Observational Cohort Study, EuroSIDA and ANRS CO3 Aquitaine Cohort. PRESENTATION
•  

IWHOD 2023, Athens, Greece, 23-25 March 2023

• Poster Presentations:
• Disruptions in testing and treatment services for hepatitis C virus during the SARS-CoV-2 epidemic among individuals with HIV susceptible for HCV reinfection: results from the EuroSIDA study presented by Anders Boyd on behalf of the EuroSIDA Study Group. 
•  
• Temporal trends in the HIV care cascade across Europe between 2016-2020: Impact of COVID-19 presented by Olga Fursa on behalf of the EuroSIDA Study Group.
•  

19th European AIDS Conference (EACS), Warsaw, Poland. 18-21 October 2023

• Oral presentations:​
• Effect of ART, immunological-virological status and prior tuberculosis on mortality among people with HIV in Europe presented by Erich Tusch on behalf of the EuroSIDA Study Group. PRESENTATION
•  
• Temporal trends and impact of COVID-19 on the HIV cascade of care across Europe between 2016-2021 presented by Lars Peters on behalf of the EuroSIDA Study Group. PRESENTATION
•  
• Disruptions in testing and treatment services for hepatitis C virus during the SARS-CoV-2 epidemic among individuals with HIV susceptible for HCV reinfection: results from the EuroSIDA study presented by Anders Boyd on the behalf of EuroSIDA Study Group. PRESENTATION Winner of EACS Rapid Abstract Award! 
  
  Poster presentation:
• Differences in integrated assessment and management of non-communicable diseases (NCDs) for people with HIV across the WHO European Region by Christian Kraef on behalf of EuroSIDA Study Group. POSTER